Myelin-Oligodendrocyte Glycoprotein
"Myelin-Oligodendrocyte Glycoprotein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A transmembrane protein present in the MYELIN SHEATH of the CENTRAL NERVOUS SYSTEM. It is one of the main autoantigens implicated in the pathogenesis of MULTIPLE SCLEROSIS.
| Descriptor ID |
D063308
|
| MeSH Number(s) |
D12.776.395.550.114.500 D12.776.543.550.195.500 D12.776.543.620.550 D12.776.631.580.530 D23.050.422.625
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Myelin-Oligodendrocyte Glycoprotein".
Below are MeSH descriptors whose meaning is more specific than "Myelin-Oligodendrocyte Glycoprotein".
This graph shows the total number of publications written about "Myelin-Oligodendrocyte Glycoprotein" by people in this website by year, and whether "Myelin-Oligodendrocyte Glycoprotein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2010 | 0 | 2 | 2 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myelin-Oligodendrocyte Glycoprotein" by people in Profiles.
-
Multiple Sclerosis Is Rare in Epstein-Barr Virus-Seronegative Children with Central Nervous System Inflammatory Demyelination. Ann Neurol. 2021 06; 89(6):1234-1239.
-
Pertussis Toxin Inhibits Encephalitogenic T-Cell Infiltration and Promotes a B-Cell-Driven Disease during Th17-EAE. Int J Mol Sci. 2021 Mar 13; 22(6).
-
CNS Autoimmune Responses in BCMA-Deficient Mice Provide Insight for the Failure of Atacicept in MS. Neurol Neuroimmunol Neuroinflamm. 2021 05; 8(3).
-
Immune-Mediated Disorders Affecting the Spinal Cord and the Spine. Curr Neurol Neurosci Rep. 2021 01 03; 21(1):3.
-
B cell function impacts the efficacy of IFN-ß therapy in EAE. J Neuroimmunol. 2020 01 15; 338:577106.
-
IFN-ß treatment requires B cells for efficacy in neuroautoimmunity. J Immunol. 2015 Mar 01; 194(5):2110-6.
-
Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis. J Neurosci Res. 2015 May; 93(5):697-706.
-
Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein. Mult Scler. 2012 Apr; 18(4):398-408.
-
Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity. J Exp Med. 2010 Aug 02; 207(8):1599-608.
-
Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci U S A. 2010 Feb 09; 107(6):2580-5.